BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22032295)

  • 1. Organometallic 3-(1H-benzimidazol-2-yl)-1H-pyrazolo[3,4-b]pyridines as potential anticancer agents.
    Stepanenko IN; Novak MS; Mühlgassner G; Roller A; Hejl M; Arion VB; Jakupec MA; Keppler BK
    Inorg Chem; 2011 Nov; 50(22):11715-28. PubMed ID: 22032295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organometallic indolo[3,2-c]quinolines versus indolo[3,2-d]benzazepines: synthesis, structural and spectroscopic characterization, and biological efficacy.
    Filak LK; Mühlgassner G; Jakupec MA; Heffeter P; Berger W; Arion VB; Keppler BK
    J Biol Inorg Chem; 2010 Aug; 15(6):903-18. PubMed ID: 20369265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugation of organoruthenium(II) 3-(1H-benzimidazol-2-yl)pyrazolo[3,4-b]pyridines and indolo[3,2-d]benzazepines to recombinant human serum albumin: a strategy to enhance cytotoxicity in cancer cells.
    Stepanenko IN; Casini A; Edafe F; Novak MS; Arion VB; Dyson PJ; Jakupec MA; Keppler BK
    Inorg Chem; 2011 Dec; 50(24):12669-79. PubMed ID: 22111668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethylenediamine-palladium(II) complexes with pyridine and its derivatives: synthesis, molecular structure and initial antitumor studies.
    Zhao G; Lin H; Yu P; Sun H; Zhu S; Su X; Chen Y
    J Inorg Biochem; 1999 Mar; 73(3):145-9. PubMed ID: 10331244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Half-sandwich Ru(η
    Huang YC; Haribabu J; Chien CM; Sabapathi G; Chou CK; Karvembu R; Venuvanalingam P; Ching WM; Tsai ML; Hsu SCN
    J Inorg Biochem; 2019 May; 194():74-84. PubMed ID: 30831392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsteroidal Anti-inflammatory-Organometallic Anticancer Compounds.
    Păunescu E; McArthur S; Soudani M; Scopelliti R; Dyson PJ
    Inorg Chem; 2016 Feb; 55(4):1788-808. PubMed ID: 26824462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of pyrazolo[3,4-b]pyridines under microwave irradiation in multi-component reactions and their antitumor and antimicrobial activities - Part 1.
    El-borai MA; Rizk HF; Abd-Aal MF; El-Deeb IY
    Eur J Med Chem; 2012 Feb; 48():92-6. PubMed ID: 22178093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facile synthesis and in-vitro antitumor activity of some pyrazolo[3,4-b]pyridines and pyrazolo[1,5-a]pyrimidines linked to a thiazolo[3,2-a]benzimidazole moiety.
    Abdel-Aziz HA; Saleh TS; El-Zahabi HS
    Arch Pharm (Weinheim); 2010 Jan; 343(1):24-30. PubMed ID: 19921685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. En route to osmium analogues of KP1019: synthesis, structure, spectroscopic properties and antiproliferative activity of trans-[Os(IV)Cl4(Hazole)2].
    Büchel GE; Stepanenko IN; Hejl M; Jakupec MA; Keppler BK; Arion VB
    Inorg Chem; 2011 Aug; 50(16):7690-7. PubMed ID: 21739939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metal-based paullones as putative CDK inhibitors for antitumor chemotherapy.
    Schmid WF; John RO; Mühlgassner G; Heffeter P; Jakupec MA; Galanski MS; Berger W; Arion VB; Keppler BK
    J Med Chem; 2007 Dec; 50(25):6343-55. PubMed ID: 17997519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-pot three-component synthesis of novel pyrazolo[3,4-b]pyridines as potent antileukemic agents.
    Barghash RF; Eldehna WM; Kovalová M; Vojáčková V; Kryštof V; Abdel-Aziz HA
    Eur J Med Chem; 2022 Jan; 227():113952. PubMed ID: 34731763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands.
    Martínez-Alonso M; Busto N; Jalón FA; Manzano BR; Leal JM; Rodríguez AM; García B; Espino G
    Inorg Chem; 2014 Oct; 53(20):11274-88. PubMed ID: 25302401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CF3 Derivatives of the Anticancer Ru(III) Complexes KP1019, NKP-1339, and Their Imidazole and Pyridine Analogues Show Enhanced Lipophilicity, Albumin Interactions, and Cytotoxicity.
    Chang SW; Lewis AR; Prosser KE; Thompson JR; Gladkikh M; Bally MB; Warren JJ; Walsby CJ
    Inorg Chem; 2016 May; 55(10):4850-63. PubMed ID: 27143338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of novel alkyl amide functionalized trifluoromethyl substituted pyrazolo[3,4-b]pyridine derivatives as potential anticancer agents.
    Chavva K; Pillalamarri S; Banda V; Gautham S; Gaddamedi J; Yedla P; Kumar CG; Banda N
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5893-5. PubMed ID: 24060486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure, electronic properties and cytotoxic activity of palladium chloride complexes with monosubstituted pyridines.
    Krogul A; Cedrowski J; Wiktorska K; Ozimiński WP; Skupińska J; Litwinienko G
    Dalton Trans; 2012 Jan; 41(2):658-66. PubMed ID: 22068915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of New Pyrazolopyridine, Furopyridine, and Pyridine Derivatives as CDK2 Inhibitors: Design, Synthesis, Docking Studies, and Anti-Proliferative Activity.
    Abdel-Rahman AA; Shaban AKF; Nassar IF; El-Kady DS; Ismail NSM; Mahmoud SF; Awad HM; El-Sayed WA
    Molecules; 2021 Jun; 26(13):. PubMed ID: 34206976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of novel anticancer ruthenium-arene pyridinylmethylene scaffolds via three-component reaction.
    Jadhav GR; Sinha S; Chhabra M; Paira P
    Bioorg Med Chem Lett; 2016 Jun; 26(11):2695-700. PubMed ID: 27090558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of pyrazolo[3,4-b]pyridine CDK1 inhibitors as anti-tumor agents.
    Lin R; Connolly PJ; Lu Y; Chiu G; Li S; Yu Y; Huang S; Li X; Emanuel SL; Middleton SA; Gruninger RH; Adams M; Fuentes-Pesquera AR; Greenberger LM
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4297-302. PubMed ID: 17532631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization, photoluminescence, anti-tumor activity, DFT calculations and molecular docking with proteins of zinc(ii) halogen substituted terpyridine compounds.
    Liang X; Jiang J; Xue X; Huang L; Ding X; Nong D; Chen H; Pan L; Ma Z
    Dalton Trans; 2019 Jul; 48(28):10488-10504. PubMed ID: 31210199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of highly cytotoxic copper(II) complexes with modified indolo[3,2-c]quinoline ligands.
    Primik MF; Göschl S; Jakupec MA; Roller A; Keppler BK; Arion VB
    Inorg Chem; 2010 Dec; 49(23):11084-95. PubMed ID: 20979395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.